{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:27:21Z","timestamp":1794652041539,"version":"4.9.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00467-022-05820-x","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T14:03:46Z","timestamp":1669730626000},"page":"3253-3264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cystic kidney disease in tuberous sclerosis complex: current knowledge and unresolved questions"],"prefix":"10.1007","volume":"38","author":[{"given":"Sebastian","family":"Gallo-Bernal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Kilcoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahna","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"5820_CR1","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske EP, J\u00f3\u017awiak S, Kingswood JC, Sampson JR et al (2016) Tuberous sclerosis complex. Nat Rev Dis Primers 2:16035. https:\/\/doi.org\/10.1038\/nrdp.2016.35","journal-title":"Nat Rev Dis Primers"},{"key":"5820_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","volume":"123","author":"H Northrup","year":"2021","unstructured":"Northrup H, Aronow ME, Bebin EM, Bissler J et al (2021) Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr Neurol 123:50\u201366. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.07.011","journal-title":"Pediatr Neurol"},{"key":"5820_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ajmg.c.31654","volume":"178","author":"JJ Bissler","year":"2018","unstructured":"Bissler JJ, Christopher Kingswood J (2018) Renal manifestation of tuberous sclerosis complex. Am J Med Genet C Semin Med Genet 178:338\u2013347. https:\/\/doi.org\/10.1002\/ajmg.c.31654","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"5820_CR4","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3389\/fneur.2020.00972","volume":"11","author":"JC Kingswood","year":"2020","unstructured":"Kingswood JC, Belousova E, Benedik MP, Carter T et al (2020) Renal manifestations of tuberous sclerosis complex: key findings from the final analysis of the TOSCA study focussing mainly on renal angiomyolipomas. Front Neurol 11:972. https:\/\/doi.org\/10.3389\/fneur.2020.00972","journal-title":"Front Neurol"},{"key":"5820_CR5","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/genes12101585","volume":"12","author":"EP Henske","year":"2021","unstructured":"Henske EP, Cornejo KM, Wu C-L (2021) Renal cell carcinoma in tuberous sclerosis complex. Genes (Basel) 12:1585. https:\/\/doi.org\/10.3390\/genes12101585","journal-title":"Genes (Basel)"},{"key":"5820_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13023-021-01917-y","volume":"16","author":"M Sauter","year":"2021","unstructured":"Sauter M, Belousova E, Benedik MP, Carter T et al (2021) Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease awareness (TOSCA). Orphanet J Rare Dis 16:301. https:\/\/doi.org\/10.1186\/s13023-021-01917-y","journal-title":"Orphanet J Rare Dis"},{"key":"5820_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0022-5347(01)63072-6","volume":"160","author":"DH Ewalt","year":"1998","unstructured":"Ewalt DH, Sheffield E, Sparagana SP, Delgado MR et al (1998) Renal lesion growth in children with tuberous sclerosis complex. J Urol 160:141\u2013145","journal-title":"J Urol"},{"key":"5820_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","volume":"14","author":"HC Lam","year":"2018","unstructured":"Lam HC, Siroky BJ, Henske EP (2018) Renal disease in tuberous sclerosis complex: pathogenesis and therapy. Nat Rev Nephrol 14:704\u2013716. https:\/\/doi.org\/10.1038\/s41581-018-0059-6","journal-title":"Nat Rev Nephrol"},{"key":"5820_CR9","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"SK Rakowski","year":"2006","unstructured":"Rakowski SK, Winterkorn EB, Paul E, Steele DJR et al (2006) Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 70:1777\u20131782. https:\/\/doi.org\/10.1038\/sj.ki.5001853","journal-title":"Kidney Int"},{"key":"5820_CR10","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/dmcn.13352","volume":"59","author":"S Amin","year":"2017","unstructured":"Amin S, Lux A, Calder N, Laugharne M et al (2017) Causes of mortality in individuals with tuberous sclerosis complex. Dev Med Child Neurol 59:612\u2013617. https:\/\/doi.org\/10.1111\/dmcn.13352","journal-title":"Dev Med Child Neurol"},{"key":"5820_CR11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.ajkd.2015.05.016","volume":"66","author":"MJC Eijkemans","year":"2015","unstructured":"Eijkemans MJC, van der Wal W, Reijnders LJ, Roes KCB et al (2015) Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands. Am J Kidney Dis 66:638\u2013645. https:\/\/doi.org\/10.1053\/j.ajkd.2015.05.016","journal-title":"Am J Kidney Dis"},{"key":"5820_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/s0025-6196(12)61196-3","volume":"66","author":"CW Shepherd","year":"1991","unstructured":"Shepherd CW, Gomez MR, Lie JT, Crowson CS (1991) Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66:792\u2013796. https:\/\/doi.org\/10.1016\/s0025-6196(12)61196-3","journal-title":"Mayo Clin Proc"},{"key":"5820_CR13","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00467-018-4003-6","volume":"33","author":"P Janssens","year":"2018","unstructured":"Janssens P, van Hoeve K, de Waele L, de Rechter S et al (2018) Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study. Pediatr Nephrol 33:2085\u20132093. https:\/\/doi.org\/10.1007\/s00467-018-4003-6","journal-title":"Pediatr Nephrol"},{"key":"5820_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00439-002-0738-y","volume":"111","author":"PS Roberts","year":"2002","unstructured":"Roberts PS, Chung J, Jozwiak S, Dabora SL et al (2002) SNP identification, haplotype analysis, and parental origin of mutations in TSC2. Hum Genet 111:96\u2013101. https:\/\/doi.org\/10.1007\/s00439-002-0738-y","journal-title":"Hum Genet"},{"key":"5820_CR15","doi-asserted-by":"publisher","first-page":"e1005637","DOI":"10.1371\/journal.pgen.1005637","volume":"11","author":"ME Tyburczy","year":"2015","unstructured":"Tyburczy ME, Dies KA, Glass J, Camposano S et al (2015) Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLoS Genet 11:e1005637. https:\/\/doi.org\/10.1371\/journal.pgen.1005637","journal-title":"PLoS Genet"},{"key":"5820_CR16","doi-asserted-by":"publisher","first-page":"15816","DOI":"10.1038\/ncomms15816","volume":"8","author":"KR Martin","year":"2017","unstructured":"Martin KR, Zhou W, Bowman MJ, Shih J et al (2017) The genomic landscape of tuberous sclerosis complex. Nat Commun 8:15816. https:\/\/doi.org\/10.1038\/ncomms15816","journal-title":"Nat Commun"},{"key":"5820_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.juro.2016.09.082","volume":"197","author":"JC Warncke","year":"2017","unstructured":"Warncke JC, Brodie KE, Grantham EC, Catarinicchia SP et al (2017) Pediatric renal angiomyolipomas in tuberous sclerosis complex. J Urol 197:500\u2013506. https:\/\/doi.org\/10.1016\/j.juro.2016.09.082","journal-title":"J Urol"},{"key":"5820_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN, Roberts PS et al (2001) Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 68:64\u201380. https:\/\/doi.org\/10.1086\/316951","journal-title":"Am J Hum Genet"},{"key":"5820_CR19","doi-asserted-by":"crossref","unstructured":"Francis J, DiMario FJ Jr. (2019) NORD\u2019s rare disease database: tuberous sclerosis. https:\/\/rarediseases.org\/rare-diseases\/tuberous-sclerosis\/. Accessed 28 October 2022.","DOI":"10.1002\/9781119142812.ch143"},{"key":"5820_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41467-020-20522-4","volume":"12","author":"H Yang","year":"2021","unstructured":"Yang H, Yu Z, Chen X, Li J et al (2021) Structural insights into TSC complex assembly and GAP activity on Rheb. Nat Commun 12:339. https:\/\/doi.org\/10.1038\/s41467-020-20522-4","journal-title":"Nat Commun"},{"key":"5820_CR21","doi-asserted-by":"publisher","first-page":"10786","DOI":"10.1038\/ncomms10786","volume":"7","author":"M Pema","year":"2016","unstructured":"Pema M, Drusian L, Chiaravalli M, Castelli M et al (2016) mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex. Nat Commun 7:10786. https:\/\/doi.org\/10.1038\/ncomms10786","journal-title":"Nat Commun"},{"key":"5820_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jpeds.2017.05.015","volume":"187","author":"BJ Siroky","year":"2017","unstructured":"Siroky BJ, Towbin AJ, Trout AT, Sch\u00e4fer H et al (2017) Improvement in renal cystic disease of tuberous sclerosis complex after treatment with mammalian target of rapamycin inhibitor. J Pediatr 187:318-322.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2017.05.015","journal-title":"J Pediatr"},{"key":"5820_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.devcel.2005.12.005","volume":"10","author":"SH Low","year":"2006","unstructured":"Low SH, Vasanth S, Larson CH, Mukherjee S et al (2006) Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev Cell 10:57\u201369. https:\/\/doi.org\/10.1016\/j.devcel.2005.12.005","journal-title":"Dev Cell"},{"key":"5820_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3390\/genes11060711","volume":"11","author":"Y Lai","year":"2020","unstructured":"Lai Y, Jiang Y (2020) Reciprocal regulation between primary cilia and mTORC1. Genes (Basel) 11:711. https:\/\/doi.org\/10.3390\/genes11060711","journal-title":"Genes (Basel)"},{"key":"5820_CR25","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"JM Shillingford","year":"2006","unstructured":"Shillingford JM, Murcia NS, Larson CH, Low SH et al (2006) The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A 103:5466\u20135471. https:\/\/doi.org\/10.1073\/pnas.0509694103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5820_CR26","doi-asserted-by":"publisher","unstructured":"Yamamoto Y, Mizushima N (2021) Autophagy and ciliogenesis. JMA J 4:207\u2013215. https:\/\/doi.org\/10.31662\/jmaj.2021-0090","DOI":"10.31662\/jmaj.2021-0090"},{"key":"5820_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/hmg\/ddn325","volume":"18","author":"TR Hartman","year":"2009","unstructured":"Hartman TR, Liu D, Zilfou JT, Robb V et al (2009) The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hum Mol Genet 18:151\u2013163. https:\/\/doi.org\/10.1093\/hmg\/ddn325","journal-title":"Hum Mol Genet"},{"key":"5820_CR28","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.prp.2016.04.005","volume":"212","author":"SM Bonsib","year":"2016","unstructured":"Bonsib SM, Boils C, Gokden N, Grignon D et al (2016) Tuberous sclerosis complex: hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms. Pathol Res Pract 212:972\u2013979. https:\/\/doi.org\/10.1016\/j.prp.2016.04.005","journal-title":"Pathol Res Pract"},{"key":"5820_CR29","doi-asserted-by":"publisher","unstructured":"Bissler JJ, Zadjali F, Bridges D, Astrinidis A et al (2019) Tuberous sclerosis complex exhibits a new renal cystogenic mechanism. Physiol Rep 7:e13983. https:\/\/doi.org\/10.14814\/phy2.13983","DOI":"10.14814\/phy2.13983"},{"key":"5820_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.gendis.2021.03.010","volume":"9","author":"P Kumar","year":"2022","unstructured":"Kumar P, Zadjali F, Yao Y, Johnson D et al (2022) Tsc2 mutation induces renal tubular cell nonautonomous disease. Genes Dis 9:187\u2013200. https:\/\/doi.org\/10.1016\/j.gendis.2021.03.010","journal-title":"Genes Dis"},{"key":"5820_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00467-017-3816-z","volume":"34","author":"A-L St\u00e5hl","year":"2019","unstructured":"St\u00e5hl A-L, Johansson K, Mossberg M, Kahn R et al (2019) Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases. Pediatr Nephrol 34:11\u201330. https:\/\/doi.org\/10.1007\/s00467-017-3816-z","journal-title":"Pediatr Nephrol"},{"key":"5820_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fmolb.2017.00037","volume":"4","author":"MAC Pomatto","year":"2017","unstructured":"Pomatto MAC, Gai C, Bussolati B, Camussi G (2017) Extracellular vesicles in renal pathophysiology. Front Mol Biosci 4:37. https:\/\/doi.org\/10.3389\/fmolb.2017.00037","journal-title":"Front Mol Biosci"},{"key":"5820_CR33","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/adc.2011.211995","volume":"96","author":"JR Yates","year":"2011","unstructured":"Yates JR, MacLean C, Higgins JNP, Humphrey A et al (2011) The Tuberous Sclerosis 2000 study: presentation, initial assessments and implications for diagnosis and management. Arch Dis Child 96:1020\u20131025. https:\/\/doi.org\/10.1136\/adc.2011.211995","journal-title":"Arch Dis Child"},{"key":"5820_CR34","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/ki.2008.485","volume":"74","author":"MB Consugar","year":"2008","unstructured":"Consugar MB, Wong WC, Lundquist PA, Rossetti S et al (2008) Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1\/TSC2 contiguous gene syndrome. Kidney Int 74:1468\u20131479. https:\/\/doi.org\/10.1038\/ki.2008.485","journal-title":"Kidney Int"},{"key":"5820_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1086\/514888","volume":"61","author":"JR Sampson","year":"1997","unstructured":"Sampson JR, Maheshwar MM, Aspinwall R, Thompson P et al (1997) Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 61:843\u2013851. https:\/\/doi.org\/10.1086\/514888","journal-title":"Am J Hum Genet"},{"key":"5820_CR36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1148\/radiol.12112087","volume":"265","author":"N Hindman","year":"2012","unstructured":"Hindman N, Ngo L, Genega EM, Melamed J et al (2012) Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology 265:468\u2013477. https:\/\/doi.org\/10.1148\/radiol.12112087","journal-title":"Radiology"},{"key":"5820_CR37","doi-asserted-by":"publisher","first-page":"826","DOI":"10.2214\/AJR.17.17973","volume":"209","author":"BK Park","year":"2017","unstructured":"Park BK (2017) Renal angiomyolipoma: radiologic classification and imaging features according to the amount of fat. AJR Am J Roentgenol 209:826\u2013835. https:\/\/doi.org\/10.2214\/AJR.17.17973","journal-title":"Am J Roentgenol"},{"key":"5820_CR38","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1148\/rg.2021210103","volume":"41","author":"MX Wang","year":"2021","unstructured":"Wang MX, Segaran N, Bhalla S, Pickhardt PJ et al (2021) Tuberous sclerosis: current update. Radiographics 41:1992\u20132010. https:\/\/doi.org\/10.1148\/rg.2021210103","journal-title":"Radiographics"},{"key":"5820_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1148\/radiol.2251011477","volume":"225","author":"K Yamakado","year":"2002","unstructured":"Yamakado K, Tanaka N, Nakagawa T, Kobayashi S et al (2002) Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 225:78\u201382. https:\/\/doi.org\/10.1148\/radiol.2251011477","journal-title":"Radiology"},{"key":"5820_CR40","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00467-020-04775-1","volume":"36","author":"P Trnka","year":"2021","unstructured":"Trnka P, Kennedy SE (2021) Renal tumors in tuberous sclerosis complex. Pediatr Nephrol 36:1427\u20131438. https:\/\/doi.org\/10.1007\/s00467-020-04775-1","journal-title":"Pediatr Nephrol"},{"key":"5820_CR41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11547-015-0572-7","volume":"121","author":"A Robert","year":"2016","unstructured":"Robert A, Leroy V, Riquet A, Gogneaux L et al (2016) Renal involvement in tuberous sclerosis complex with emphasis on cystic lesions. Radiol Med 121:402\u2013408. https:\/\/doi.org\/10.1007\/s11547-015-0572-7","journal-title":"Radiol Med"},{"key":"5820_CR42","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1148\/radiol.2252011584","volume":"225","author":"KA Casper","year":"2002","unstructured":"Casper KA, Donnelly LF, Chen B, Bissler JJ (2002) Tuberous sclerosis complex: renal imaging findings. Radiology 225:451\u2013456. https:\/\/doi.org\/10.1148\/radiol.2252011584","journal-title":"Radiology"},{"key":"5820_CR43","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1148\/radiol.2018181243","volume":"290","author":"C Gimpel","year":"2019","unstructured":"Gimpel C, Avni EF, Breysem L, Burgmaier K et al (2019) Imaging of kidney cysts and cystic kidney diseases in children: an international working group consensus statement. Radiology 290:769\u2013782. https:\/\/doi.org\/10.1148\/radiol.2018181243","journal-title":"Radiology"},{"key":"5820_CR44","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/BF00857576","volume":"7","author":"J Bernstein","year":"1993","unstructured":"Bernstein J (1993) Glomerulocystic kidney disease \u2013 nosological considerations. Pediatr Nephrol 7:464\u2013470. https:\/\/doi.org\/10.1007\/BF00857576","journal-title":"Pediatr Nephrol"},{"key":"5820_CR45","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1148\/radiol.2020192070","volume":"296","author":"MP Wilson","year":"2020","unstructured":"Wilson MP, Patel D, Murad MH, McInnes MDF et al (2020) Diagnostic performance of MRI in the detection of renal lipid-poor angiomyolipomas: a systematic review and meta-analysis. Radiology 296:511\u2013520. https:\/\/doi.org\/10.1148\/radiol.2020192070","journal-title":"Radiology"},{"key":"5820_CR46","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00467-020-04835-6","volume":"36","author":"JP Chan","year":"2021","unstructured":"Chan JP, Back SJ, Vatsky S, Calle-Toro JS et al (2021) Utility of contrast-enhanced ultrasound for solid mass surveillance and characterization in children with tuberous sclerosis complex: an initial experience. Pediatr Nephrol 36:1775\u20131784. https:\/\/doi.org\/10.1007\/s00467-020-04835-6","journal-title":"Pediatr Nephrol"},{"key":"5820_CR47","doi-asserted-by":"publisher","first-page":"e190091","DOI":"10.1148\/rycan.2020190091","volume":"2","author":"C Raab","year":"2020","unstructured":"Raab C, Gilligan LA, Trout AT, Krueger DA et al (2020) mTOR inhibitor therapy for tuberous sclerosis complex: longitudinal study of muscle mass determined by abdominal cross-sectional imaging with CT and MRI. Radiol Imaging Cancer 2:e190091. https:\/\/doi.org\/10.1148\/rycan.2020190091","journal-title":"Radiol Imaging Cancer"},{"key":"5820_CR48","doi-asserted-by":"publisher","unstructured":"Sasongko TH, Ismail NFD, Zabidi-Hussin Z (2016) Rapamycin and rapalogs for tuberous sclerosis complex. Cochrane Database Syst Rev 7:CD011272. https:\/\/doi.org\/10.1002\/14651858.CD011272.pub2","DOI":"10.1002\/14651858.CD011272.pub2"},{"key":"5820_CR49","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s11255-019-02292-1","volume":"51","author":"C-H Lin","year":"2019","unstructured":"Lin C-H, Chao C-T, Wu M-Y, Lo W-C et al (2019) Use of mammalian target of rapamycin inhibitors in patient with autosomal dominant polycystic kidney disease: an updated meta-analysis. Int Urol Nephrol 51:2015\u20132025. https:\/\/doi.org\/10.1007\/s11255-019-02292-1","journal-title":"Int Urol Nephrol"},{"key":"5820_CR50","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz G, Budde K, Mannaa M, N\u00fcrnberger J et al (2010) Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med 363:830\u2013840. https:\/\/doi.org\/10.1056\/NEJMoa1003491","journal-title":"New Engl J Med"},{"key":"5820_CR51","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra AL, Poster D, Kistler AD, Krauer F et al (2010) Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med 363:820\u2013829. https:\/\/doi.org\/10.1056\/NEJMoa0907419","journal-title":"New Engl J Med"},{"key":"5820_CR52","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","volume":"38","author":"P Yang","year":"2014","unstructured":"Yang P, Cornejo KM, Sadow PM, Cheng L et al (2014) Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol 38:895\u2013909. https:\/\/doi.org\/10.1097\/PAS.0000000000000237","journal-title":"Am J Surg Pathol"},{"key":"5820_CR53","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/ajmg.a.37644","volume":"170","author":"A Peron","year":"2016","unstructured":"Peron A, Vignoli A, la Briola F, Volpi A et al (2016) Do patients with tuberous sclerosis complex have an increased risk for malignancies? Am J Med Genet A 170:1538\u20131544. https:\/\/doi.org\/10.1002\/ajmg.a.37644","journal-title":"Am J Med Genet A"},{"key":"5820_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1749-6632.1991.tb37746.x","volume":"615","author":"J Bernstein","year":"1991","unstructured":"Bernstein J, Robbins TO (1991) Renal involvement in tuberous sclerosis. Ann N Y Acad Sci 615:36\u201349. https:\/\/doi.org\/10.1111\/j.1749-6632.1991.tb37746.x","journal-title":"Ann N Y Acad Sci"},{"key":"5820_CR55","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00247-011-2319-5","volume":"42","author":"RT Downey","year":"2012","unstructured":"Downey RT, Dillman JR, Ladino-Torres MF, McHugh JB et al (2012) CT and MRI appearances and radiologic staging of pediatric renal cell carcinoma. Pediatr Radiol 42:410\u2013417. https:\/\/doi.org\/10.1007\/s00247-011-2319-5","journal-title":"Pediatr Radiol"},{"key":"5820_CR56","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1148\/rg.2017160189","volume":"37","author":"EM Chung","year":"2017","unstructured":"Chung EM, Lattin GE, Fagen KE, Kim AM et al (2017) Renal tumors of childhood: radiologic-pathologic correlation part 2. The 2nd decade: from the radiologic pathology archives. Radiographics 37:1538\u20131558. https:\/\/doi.org\/10.1148\/rg.2017160189","journal-title":"Radiographics"},{"key":"5820_CR57","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.juro.2018.03.076","volume":"200","author":"AF Saltzman","year":"2018","unstructured":"Saltzman AF, Carrasco A, Colvin AN, Meyers ML et al (2018) Can a modified Bosniak classification system risk stratify pediatric cystic renal masses? J Urol 200:434\u2013439. https:\/\/doi.org\/10.1016\/j.juro.2018.03.076","journal-title":"J Urol"},{"key":"5820_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1148\/radiology.158.1.3510019","volume":"158","author":"MA Bosniak","year":"1986","unstructured":"Bosniak MA (1986) The current radiological approach to renal cysts. Radiology 158:1\u201310. https:\/\/doi.org\/10.1148\/radiology.158.1.3510019","journal-title":"Radiology"},{"key":"5820_CR59","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1148\/radiol.2019182646","volume":"292","author":"SG Silverman","year":"2019","unstructured":"Silverman SG, Pedrosa I, Ellis JH, Hindman NM et al (2019) Bosniak classification of cystic renal masses, version 2019: an update proposal and needs assessment. Radiology 292:475\u2013488. https:\/\/doi.org\/10.1148\/radiol.2019182646","journal-title":"Radiology"},{"key":"5820_CR60","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2214\/AJR.20.23656","volume":"216","author":"JR Tse","year":"2021","unstructured":"Tse JR, Shen J, Shen L, Yoon L et al (2021) Bosniak classification of cystic renal masses version 2019: comparison of categorization using CT and MRI. AJR Am J Roentgenol 216:412\u2013420. https:\/\/doi.org\/10.2214\/AJR.20.23656","journal-title":"Am J Roentgenol"},{"key":"5820_CR61","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1200\/JCO.2018.79.2341","volume":"36","author":"A Sanchez","year":"2018","unstructured":"Sanchez A, Feldman AS, Hakimi AA (2018) Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation. J Clin Oncol 36:3591\u20133600. https:\/\/doi.org\/10.1200\/JCO.2018.79.2341","journal-title":"J Clin Oncol"},{"key":"5820_CR62","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00439-006-0308-9","volume":"121","author":"P Kozlowski","year":"2007","unstructured":"Kozlowski P, Roberts P, Dabora S, Franz D et al (2007) Identification of 54 large deletions\/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet 121:389\u2013400. https:\/\/doi.org\/10.1007\/s00439-006-0308-9","journal-title":"Hum Genet"},{"key":"5820_CR63","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1294-328","volume":"8","author":"PT Brook-Carter","year":"1994","unstructured":"Brook-Carter PT, Peral B, Ward CJ, Thompson P et al (1994) Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease \u2013 a contiguous gene syndrome. Nat Genet 8:328\u2013332. https:\/\/doi.org\/10.1038\/ng1294-328","journal-title":"Nat Genet"},{"key":"5820_CR64","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5414\/CN110476","volume":"97","author":"S Shang","year":"2022","unstructured":"Shang S, Mei Y, Wang T, Zheng X et al (2022) Diagnosis and genotype-phenotype correlation in patients with PKD1\/TSC2 contiguous gene deletion syndrome. Clin Nephrol 97:328\u2013338. https:\/\/doi.org\/10.5414\/CN110476","journal-title":"Clin Nephrol"},{"key":"5820_CR65","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s00247-014-3147-1","volume":"45","author":"SJ Back","year":"2015","unstructured":"Back SJ, Andronikou S, Kilborn T, Kaplan BS et al (2015) Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome. Pediatr Radiol 45:386\u2013395. https:\/\/doi.org\/10.1007\/s00247-014-3147-1","journal-title":"Pediatr Radiol"},{"key":"5820_CR66","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41581-019-0155-2","volume":"15","author":"C Gimpel","year":"2019","unstructured":"Gimpel C, Bergmann C, Bockenhauer D, Breysem L et al (2019) International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people. Nat Rev Nephrol 15:713\u2013726. https:\/\/doi.org\/10.1038\/s41581-019-0155-2","journal-title":"Nat Rev Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05820-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T14:05:52Z","timestamp":1693317952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05820-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["5820"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05820-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}